This report aims to provide a comprehensive presentation of the global market for Human Hepatitis B Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Hepatitis B Immunoglobulin. This report contains market size and forecasts of Human Hepatitis B Immunoglobulin in global, including the following market information:
Global Human Hepatitis B Immunoglobulin Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global Human Hepatitis B Immunoglobulin Market Sales, 2019-2024, 2024-2029, (K Units)
Global top five Human Hepatitis B Immunoglobulin companies in 2023 (%)
The global Human Hepatitis B Immunoglobulin market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Hepatitis B Immunoglobulin include Baxter, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, China Biologic and Tiantan Biologic, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Hepatitis B Immunoglobulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Hepatitis B Immunoglobulin Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Human Hepatitis B Immunoglobulin Market Segment Percentages, by Type, 2023 (%)
100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Global Human Hepatitis B Immunoglobulin Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Human Hepatitis B Immunoglobulin Market Segment Percentages, by Application, 2023 (%)
Hepatitis B Carrier
Hepatitis B Close Contacts
Global Human Hepatitis B Immunoglobulin Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Human Hepatitis B Immunoglobulin Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Hepatitis B Immunoglobulin revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Human Hepatitis B Immunoglobulin revenues share in global market, 2023 (%)
Key companies Human Hepatitis B Immunoglobulin sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Human Hepatitis B Immunoglobulin sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Hepatitis B Immunoglobulin, market overview.
Chapter 2: Global Human Hepatitis B Immunoglobulin market size in revenue and volume.
Chapter 3: Detailed analysis of Human Hepatitis B Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Hepatitis B Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Hepatitis B Immunoglobulin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Hepatitis B Immunoglobulin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Hepatitis B Immunoglobulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Hepatitis B Immunoglobulin Overall Market Size
2.1 Global Human Hepatitis B Immunoglobulin Market Size: 2022 VS 2031
2.2 Global Human Hepatitis B Immunoglobulin Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Human Hepatitis B Immunoglobulin Sales: 2019-2031
3 Company Landscape
3.1 Top Human Hepatitis B Immunoglobulin Players in Global Market
3.2 Top Global Human Hepatitis B Immunoglobulin Companies Ranked by Revenue
3.3 Global Human Hepatitis B Immunoglobulin Revenue by Companies
3.4 Global Human Hepatitis B Immunoglobulin Sales by Companies
3.5 Global Human Hepatitis B Immunoglobulin Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Human Hepatitis B Immunoglobulin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Hepatitis B Immunoglobulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Hepatitis B Immunoglobulin Players in Global Market
3.8.1 List of Global Tier 1 Human Hepatitis B Immunoglobulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Hepatitis B Immunoglobulin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Hepatitis B Immunoglobulin Market Size Markets, 2022 & 2031
4.1.2 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
4.1.3 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
4.1.4 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
4.2 By Type - Global Human Hepatitis B Immunoglobulin Revenue & Forecasts
4.2.1 By Type - Global Human Hepatitis B Immunoglobulin Revenue, 2019-2024
4.2.2 By Type - Global Human Hepatitis B Immunoglobulin Revenue, 2024-2031
4.2.3 By Type - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
4.3 By Type - Global Human Hepatitis B Immunoglobulin Sales & Forecasts
4.3.1 By Type - Global Human Hepatitis B Immunoglobulin Sales, 2019-2024
4.3.2 By Type - Global Human Hepatitis B Immunoglobulin Sales, 2024-2031
4.3.3 By Type - Global Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
4.4 By Type - Global Human Hepatitis B Immunoglobulin Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Hepatitis B Immunoglobulin Market Size, 2022 & 2031
5.1.2 Hepatitis B Carrier
5.1.3 Hepatitis B Close Contacts
5.2 By Application - Global Human Hepatitis B Immunoglobulin Revenue & Forecasts
5.2.1 By Application - Global Human Hepatitis B Immunoglobulin Revenue, 2019-2024
5.2.2 By Application - Global Human Hepatitis B Immunoglobulin Revenue, 2024-2031
5.2.3 By Application - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
5.3 By Application - Global Human Hepatitis B Immunoglobulin Sales & Forecasts
5.3.1 By Application - Global Human Hepatitis B Immunoglobulin Sales, 2019-2024
5.3.2 By Application - Global Human Hepatitis B Immunoglobulin Sales, 2024-2031
5.3.3 By Application - Global Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
5.4 By Application - Global Human Hepatitis B Immunoglobulin Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Human Hepatitis B Immunoglobulin Market Size, 2022 & 2031
6.2 By Region - Global Human Hepatitis B Immunoglobulin Revenue & Forecasts
6.2.1 By Region - Global Human Hepatitis B Immunoglobulin Revenue, 2019-2024
6.2.2 By Region - Global Human Hepatitis B Immunoglobulin Revenue, 2024-2031
6.2.3 By Region - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
6.3 By Region - Global Human Hepatitis B Immunoglobulin Sales & Forecasts
6.3.1 By Region - Global Human Hepatitis B Immunoglobulin Sales, 2019-2024
6.3.2 By Region - Global Human Hepatitis B Immunoglobulin Sales, 2024-2031
6.3.3 By Region - Global Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Human Hepatitis B Immunoglobulin Revenue, 2019-2031
6.4.2 By Country - North America Human Hepatitis B Immunoglobulin Sales, 2019-2031
6.4.3 US Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.4.4 Canada Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.4.5 Mexico Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Human Hepatitis B Immunoglobulin Revenue, 2019-2031
6.5.2 By Country - Europe Human Hepatitis B Immunoglobulin Sales, 2019-2031
6.5.3 Germany Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5.4 France Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5.5 U.K. Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5.6 Italy Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5.7 Russia Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5.8 Nordic Countries Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.5.9 Benelux Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Human Hepatitis B Immunoglobulin Revenue, 2019-2031
6.6.2 By Region - Asia Human Hepatitis B Immunoglobulin Sales, 2019-2031
6.6.3 China Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.6.4 Japan Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.6.5 South Korea Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.6.6 Southeast Asia Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.6.7 India Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Human Hepatitis B Immunoglobulin Revenue, 2019-2031
6.7.2 By Country - South America Human Hepatitis B Immunoglobulin Sales, 2019-2031
6.7.3 Brazil Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.7.4 Argentina Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Sales, 2019-2031
6.8.3 Turkey Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.8.4 Israel Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.8.5 Saudi Arabia Human Hepatitis B Immunoglobulin Market Size, 2019-2031
6.8.6 UAE Human Hepatitis B Immunoglobulin Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Human Hepatitis B Immunoglobulin Major Product Offerings
7.1.4 Baxter Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.1.5 Baxter Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Human Hepatitis B Immunoglobulin Major Product Offerings
7.2.4 CSL Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.2.5 CSL Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Human Hepatitis B Immunoglobulin Major Product Offerings
7.3.4 Bayer Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.3.5 Bayer Key News & Latest Developments
7.4 Grifols
7.4.1 Grifols Company Summary
7.4.2 Grifols Business Overview
7.4.3 Grifols Human Hepatitis B Immunoglobulin Major Product Offerings
7.4.4 Grifols Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.4.5 Grifols Key News & Latest Developments
7.5 Octapharma
7.5.1 Octapharma Company Summary
7.5.2 Octapharma Business Overview
7.5.3 Octapharma Human Hepatitis B Immunoglobulin Major Product Offerings
7.5.4 Octapharma Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.5.5 Octapharma Key News & Latest Developments
7.6 Shanghai RAAS
7.6.1 Shanghai RAAS Company Summary
7.6.2 Shanghai RAAS Business Overview
7.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Major Product Offerings
7.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.6.5 Shanghai RAAS Key News & Latest Developments
7.7 Hualan Biological
7.7.1 Hualan Biological Company Summary
7.7.2 Hualan Biological Business Overview
7.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Major Product Offerings
7.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.7.5 Hualan Biological Key News & Latest Developments
7.8 China Biologic
7.8.1 China Biologic Company Summary
7.8.2 China Biologic Business Overview
7.8.3 China Biologic Human Hepatitis B Immunoglobulin Major Product Offerings
7.8.4 China Biologic Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.8.5 China Biologic Key News & Latest Developments
7.9 Tiantan Biologic
7.9.1 Tiantan Biologic Company Summary
7.9.2 Tiantan Biologic Business Overview
7.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Major Product Offerings
7.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.9.5 Tiantan Biologic Key News & Latest Developments
7.10 Shuanglin Bio-pharmacy
7.10.1 Shuanglin Bio-pharmacy Company Summary
7.10.2 Shuanglin Bio-pharmacy Business Overview
7.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Major Product Offerings
7.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.10.5 Shuanglin Bio-pharmacy Key News & Latest Developments
7.11 Sichuan Yuanda Shuyang
7.11.1 Sichuan Yuanda Shuyang Company Summary
7.11.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Business Overview
7.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Major Product Offerings
7.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.11.5 Sichuan Yuanda Shuyang Key News & Latest Developments
7.12 Boya Bio-pharmaceutical
7.12.1 Boya Bio-pharmaceutical Company Summary
7.12.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Business Overview
7.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Major Product Offerings
7.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.12.5 Boya Bio-pharmaceutical Key News & Latest Developments
7.13 Shanghai Institute of Biological
7.13.1 Shanghai Institute of Biological Company Summary
7.13.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Business Overview
7.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Major Product Offerings
7.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales and Revenue in Global (2019-2024)
7.13.5 Shanghai Institute of Biological Key News & Latest Developments
8 Global Human Hepatitis B Immunoglobulin Production Capacity, Analysis
8.1 Global Human Hepatitis B Immunoglobulin Production Capacity, 2019-2031
8.2 Human Hepatitis B Immunoglobulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Hepatitis B Immunoglobulin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Hepatitis B Immunoglobulin Supply Chain Analysis
10.1 Human Hepatitis B Immunoglobulin Industry Value Chain
10.2 Human Hepatitis B Immunoglobulin Upstream Market
10.3 Human Hepatitis B Immunoglobulin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Hepatitis B Immunoglobulin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Hepatitis B Immunoglobulin in Global Market
Table 2. Top Human Hepatitis B Immunoglobulin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Hepatitis B Immunoglobulin Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Human Hepatitis B Immunoglobulin Revenue Share by Companies, 2019-2024
Table 5. Global Human Hepatitis B Immunoglobulin Sales by Companies, (K Units), 2019-2024
Table 6. Global Human Hepatitis B Immunoglobulin Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Human Hepatitis B Immunoglobulin Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Human Hepatitis B Immunoglobulin Product Type
Table 9. List of Global Tier 1 Human Hepatitis B Immunoglobulin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Hepatitis B Immunoglobulin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Human Hepatitis B Immunoglobulin Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Human Hepatitis B Immunoglobulin Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Human Hepatitis B Immunoglobulin Sales (K Units), 2019-2024
Table 15. By Type - Global Human Hepatitis B Immunoglobulin Sales (K Units), 2024-2031
Table 16. By Application ? Global Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Human Hepatitis B Immunoglobulin Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Human Hepatitis B Immunoglobulin Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Human Hepatitis B Immunoglobulin Sales (K Units), 2019-2024
Table 20. By Application - Global Human Hepatitis B Immunoglobulin Sales (K Units), 2024-2031
Table 21. By Region ? Global Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Human Hepatitis B Immunoglobulin Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Human Hepatitis B Immunoglobulin Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Human Hepatitis B Immunoglobulin Sales (K Units), 2019-2024
Table 25. By Region - Global Human Hepatitis B Immunoglobulin Sales (K Units), 2024-2031
Table 26. By Country - North America Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Human Hepatitis B Immunoglobulin Sales, (K Units), 2019-2024
Table 29. By Country - North America Human Hepatitis B Immunoglobulin Sales, (K Units), 2024-2031
Table 30. By Country - Europe Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Human Hepatitis B Immunoglobulin Sales, (K Units), 2019-2024
Table 33. By Country - Europe Human Hepatitis B Immunoglobulin Sales, (K Units), 2024-2031
Table 34. By Region - Asia Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Human Hepatitis B Immunoglobulin Sales, (K Units), 2019-2024
Table 37. By Region - Asia Human Hepatitis B Immunoglobulin Sales, (K Units), 2024-2031
Table 38. By Country - South America Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Human Hepatitis B Immunoglobulin Sales, (K Units), 2019-2024
Table 41. By Country - South America Human Hepatitis B Immunoglobulin Sales, (K Units), 2024-2031
Table 42. By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Sales, (K Units), 2024-2031
Table 46. Baxter Company Summary
Table 47. Baxter Human Hepatitis B Immunoglobulin Product Offerings
Table 48. Baxter Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Baxter Key News & Latest Developments
Table 50. CSL Company Summary
Table 51. CSL Human Hepatitis B Immunoglobulin Product Offerings
Table 52. CSL Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. CSL Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Human Hepatitis B Immunoglobulin Product Offerings
Table 56. Bayer Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Bayer Key News & Latest Developments
Table 58. Grifols Company Summary
Table 59. Grifols Human Hepatitis B Immunoglobulin Product Offerings
Table 60. Grifols Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Grifols Key News & Latest Developments
Table 62. Octapharma Company Summary
Table 63. Octapharma Human Hepatitis B Immunoglobulin Product Offerings
Table 64. Octapharma Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Octapharma Key News & Latest Developments
Table 66. Shanghai RAAS Company Summary
Table 67. Shanghai RAAS Human Hepatitis B Immunoglobulin Product Offerings
Table 68. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Shanghai RAAS Key News & Latest Developments
Table 70. Hualan Biological Company Summary
Table 71. Hualan Biological Human Hepatitis B Immunoglobulin Product Offerings
Table 72. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Hualan Biological Key News & Latest Developments
Table 74. China Biologic Company Summary
Table 75. China Biologic Human Hepatitis B Immunoglobulin Product Offerings
Table 76. China Biologic Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. China Biologic Key News & Latest Developments
Table 78. Tiantan Biologic Company Summary
Table 79. Tiantan Biologic Human Hepatitis B Immunoglobulin Product Offerings
Table 80. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Tiantan Biologic Key News & Latest Developments
Table 82. Shuanglin Bio-pharmacy Company Summary
Table 83. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Offerings
Table 84. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Shuanglin Bio-pharmacy Key News & Latest Developments
Table 86. Sichuan Yuanda Shuyang Company Summary
Table 87. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Offerings
Table 88. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Sichuan Yuanda Shuyang Key News & Latest Developments
Table 90. Boya Bio-pharmaceutical Company Summary
Table 91. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Offerings
Table 92. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. Boya Bio-pharmaceutical Key News & Latest Developments
Table 94. Shanghai Institute of Biological Company Summary
Table 95. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Offerings
Table 96. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. Shanghai Institute of Biological Key News & Latest Developments
Table 98. Human Hepatitis B Immunoglobulin Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Human Hepatitis B Immunoglobulin Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Human Hepatitis B Immunoglobulin Production by Region, 2019-2024 (K Units)
Table 101. Global Human Hepatitis B Immunoglobulin Production by Region, 2024-2031 (K Units)
Table 102. Human Hepatitis B Immunoglobulin Market Opportunities & Trends in Global Market
Table 103. Human Hepatitis B Immunoglobulin Market Drivers in Global Market
Table 104. Human Hepatitis B Immunoglobulin Market Restraints in Global Market
Table 105. Human Hepatitis B Immunoglobulin Raw Materials
Table 106. Human Hepatitis B Immunoglobulin Raw Materials Suppliers in Global Market
Table 107. Typical Human Hepatitis B Immunoglobulin Downstream
Table 108. Human Hepatitis B Immunoglobulin Downstream Clients in Global Market
Table 109. Human Hepatitis B Immunoglobulin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin Segment by Type in 2022
Figure 2. Human Hepatitis B Immunoglobulin Segment by Application in 2022
Figure 3. Global Human Hepatitis B Immunoglobulin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Hepatitis B Immunoglobulin Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Human Hepatitis B Immunoglobulin Revenue, 2019-2031 (US$, Mn)
Figure 7. Human Hepatitis B Immunoglobulin Sales in Global Market: 2019-2031 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Hepatitis B Immunoglobulin Revenue in 2022
Figure 9. By Type - Global Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 11. By Type - Global Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 12. By Type - Global Human Hepatitis B Immunoglobulin Price (USD/Unit), 2019-2031
Figure 13. By Application - Global Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 15. By Application - Global Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 16. By Application - Global Human Hepatitis B Immunoglobulin Price (USD/Unit), 2019-2031
Figure 17. By Region - Global Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 20. By Region - Global Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 21. By Country - North America Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 22. By Country - North America Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 23. US Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 28. Germany Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 29. France Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 37. China Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 41. India Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 43. By Country - South America Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 44. Brazil Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share, 2019-2031
Figure 48. Turkey Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Human Hepatitis B Immunoglobulin Revenue, (US$, Mn), 2019-2031
Figure 52. Global Human Hepatitis B Immunoglobulin Production Capacity (K Units), 2019-2031
Figure 53. The Percentage of Production Human Hepatitis B Immunoglobulin by Region, 2022 VS 2031
Figure 54. Human Hepatitis B Immunoglobulin Industry Value Chain
Figure 55. Marketing Channels
